SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001654954-21-008125
Filing Date
2021-07-22
Accepted
2021-07-22 16:06:22
Documents
4
Period of Report
2021-07-21
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT vtgn8k_july212021.htm 8-K 35502
2 INDEMNIFICATION AGREEMENT, DATED JULY 21, 2021 ex10-1.htm EX-10.1 58008
3 PRESS RELEASE ex99-1.htm EX-99 16036
4 IMAGE vistagen.jpg GRAPHIC 4408
  Complete submission text file 0001654954-21-008125.txt   117067
Mailing Address 343 ALLERTON AVENUE SOUTH SAN FRANCISCO CA 94080
Business Address 343 ALLERTON AVENUE SOUTH SAN FRANCISCO CA 94080 650-577-3600
VistaGen Therapeutics, Inc. (Filer) CIK: 0001411685 (see all company filings)

IRS No.: 205093315 | State of Incorp.: NV | Fiscal Year End: 0331
Type: 8-K | Act: 34 | File No.: 001-37761 | Film No.: 211107674
SIC: 2834 Pharmaceutical Preparations